Review: New diagnostic and therapeutic avenues for mesothelioma

Usman Zafar Paracha1, Khezar Hayat2, Muhammad Ali2

  • 1School of Pharmacy, Hajvery University, Lahore, Pakistan.

Insights

Mesothelioma, a rare cancer linked to asbestos, has a poor prognosis. New diagnostic tools and therapies like immunotherapy offer hope for fighting this aggressive disease.

Area of Science:

  • Oncology
  • Environmental Health

Background:

  • Mesothelioma is a rare cancer of the mesothelium.
  • It is primarily caused by asbestos or nanofiber exposure.
  • The median survival for mesothelioma patients is less than one year.

Purpose of the Study:

  • To review recent advancements in diagnosing and treating mesothelioma.
  • To highlight the urgent need for improved strategies against this severe cancer.

Main Methods:

  • Review of current diagnostic tools, including biomarkers and biotechnological procedures.
  • Overview of therapeutic strategies, encompassing chemotherapy, immunotherapy, gene therapy, and alternative treatments.

Main Results:

  • Emerging diagnostic methods show promise for earlier detection.
  • Novel therapeutic approaches, including immunotherapy and gene therapy, are being explored.
  • A combination of strategies may be necessary for effective mesothelioma management.

Conclusions:

  • Significant progress is being made in mesothelioma diagnostics and therapeutics.
  • Continued research into biomarkers and advanced therapies is crucial.
  • Addressing the challenges of mesothelioma requires a multi-faceted approach.